menu search

Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit

Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit
BOSTON, May 17, 2023 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that Laurence Reid, Ph.D., Chief Executive Officer, will participate in a fireside chat at the Barclays 2023 Gene Editing and Gene Therapy Summit on […] The post Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy... Read More
Posted: May 17 2023, 20:30
Author Name: forextv
Views: 081575

Search within

Pages Search Results: